Literature DB >> 1449242

Adenosine: a potential mediator of seizure arrest and postictal refractoriness.

M J During1, D D Spencer.   

Abstract

Adenosine is a potent inhibitory neuromodulator and has been proposed as an endogenous anticonvulsant. Depth electrodes modified to include a microdialysis probe were implanted for 10 to 16 days in the hippocampi of 4 patients with intractable complex partial epilepsy to test the hypothesis that during seizures extracellular adenosine reaches levels that may depress epileptiform activity. Samples were collected bilaterally at 3-minute intervals before, during, and after a single, spontaneous-onset seizure in each patient. All seizures commenced in one hippocampus and propagated to the contralateral hippocampus. Extracellular adenosine levels increased by 6- to 31-fold with the increase significantly greater in the epileptogenic hippocampus. During seizures, levels of adenosine in the dialysate reached concentrations as high as 2.5 microM, reflecting extracellular concentrations of approximately 65 microM. Adenosine at concentrations of 40 to 50 microM depresses epileptiform activity in vitro, so the levels we report may suppress seizure activity in vivo. Moreover, adenosine levels remain elevated above basal values for the entire 18-minute postictal period. These data support the role of adenosine in mediating seizure arrest and postictal refractoriness and suggest that treatments which facilitate adenosine may be effective in preventing seizures.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1449242     DOI: 10.1002/ana.410320504

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  129 in total

Review 1.  Future prospects for the drug treatment of epilepsy.

Authors:  A Nicolson; J P Leach
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Upregulation of adenosine kinase in astrocytes in experimental and human temporal lobe epilepsy.

Authors:  Eleonora Aronica; Emanuele Zurolo; Anand Iyer; Marjolein de Groot; Jasper Anink; Caterina Carbonell; Erwin A van Vliet; Johannes C Baayen; Detlev Boison; Jan A Gorter
Journal:  Epilepsia       Date:  2011-06-02       Impact factor: 5.864

Review 3.  Presynaptic modulation controlling neuronal excitability and epileptogenesis: role of kainate, adenosine and neuropeptide Y receptors.

Authors:  João O Malva; Ana P Silva; Rodrigo A Cunha
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

4.  Adenosine dysfunction and adenosine kinase in epileptogenesis.

Authors:  Detlev Boison
Journal:  Open Neurosci J       Date:  2010-01-01

5.  Real time adenosine fluctuations detected with fast-scan cyclic voltammetry in the rat striatum and motor cortex.

Authors:  Ekue B Adamah-Biassi; Antoine G Almonte; Evgeny Blagovechtchenski; Valentina P Grinevich; Jeff L Weiner; Keith D Bonin; Evgeny A Budygin
Journal:  J Neurosci Methods       Date:  2015-08-24       Impact factor: 2.390

Review 6.  Glial adenosine kinase--a neuropathological marker of the epileptic brain.

Authors:  Eleonora Aronica; Ursula S Sandau; Anand Iyer; Detlev Boison
Journal:  Neurochem Int       Date:  2013-02-04       Impact factor: 3.921

7.  Early temporal changes in ecto-nucleotidase activity after cortical stab injury in rat.

Authors:  Nadezda Nedeljkovic; Ivana Bjelobaba; Irena Lavrnja; Danijela Stojkov; Sanja Pekovic; Ljubisav Rakic; Mirjana Stojiljkovic
Journal:  Neurochem Res       Date:  2007-11-10       Impact factor: 3.996

8.  Tonabersat Prevents Inflammatory Damage in the Central Nervous System by Blocking Connexin43 Hemichannels.

Authors:  Yeri Kim; Jarred M Griffin; Mohd N Mat Nor; Jie Zhang; Peter S Freestone; Helen V Danesh-Meyer; Ilva D Rupenthal; Monica Acosta; Louise F B Nicholson; Simon J O'Carroll; Colin R Green
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 9.  Release and actions of adenosine in the central nervous system.

Authors:  M J Higgins; H Hosseinzadeh; D G MacGregor; H Ogilvy; T W Stone
Journal:  Pharm World Sci       Date:  1994-04-15

10.  A role for a specific cholesterol interaction in stabilizing the Apo configuration of the human A(2A) adenosine receptor.

Authors:  Edward Lyman; Chris Higgs; Byungchan Kim; Dmitry Lupyan; John C Shelley; Ramy Farid; Gregory A Voth
Journal:  Structure       Date:  2009-12-09       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.